Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 No-Brainer Biotech Stocks to Buy in November


Some investing decisions are really hard to make. Others, though, can be quick and easy. That's the case when the stocks offer compelling growth prospects that are undeniable.

We asked three Motley Fool contributors to pick no-brainer biotech stocks to buy in November. Here's why they chose Bristol Myers Squibb (NYSE: BMY), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX).

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments